Great Basin Scientific (NASDAQ: GBSN) and Exactech (NASDAQ:EXAC) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

Volatility & Risk

Great Basin Scientific has a beta of 5.09, indicating that its share price is 409% more volatile than the S&P 500. Comparatively, Exactech has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500.

Insider & Institutional Ownership

64.1% of Exactech shares are owned by institutional investors. 28.3% of Exactech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings for Great Basin Scientific and Exactech, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Great Basin Scientific 0 0 0 0 N/A
Exactech 0 3 0 0 2.00

Exactech has a consensus target price of $42.00, indicating a potential upside of 0.36%. Given Exactech’s higher possible upside, analysts clearly believe Exactech is more favorable than Great Basin Scientific.

Profitability

This table compares Great Basin Scientific and Exactech’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Great Basin Scientific 2,588.36% N/A 168.06%
Exactech 0.30% 7.39% 5.98%

Valuation & Earnings

This table compares Great Basin Scientific and Exactech’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Great Basin Scientific $3.15 million 0.09 -$30.80 million N/A N/A
Exactech $262.96 million 2.28 $43.51 million $0.04 1,046.51

Exactech has higher revenue and earnings than Great Basin Scientific.

Summary

Exactech beats Great Basin Scientific on 7 of the 10 factors compared between the two stocks.

Great Basin Scientific Company Profile

Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious diseases, especially hospital-acquired infections. Its commercially available tests are clostridium difficile (C. diff) and Group B Strep. Its system includes an analyzer and a diagnostic cartridge. Each analyzer contains a module into, which individual test cartridges are placed. Its other diagnostic assays in the late stages of product development include a pre-surgical nasal screen for Staphylococcus aureus (SA), food borne pathogen panel, panel for candida blood infections, test for pertussis and a test for Chlamydia tracomatis (CT)/Neisseria gonorrhea (NG). The Company also has a pipeline of assays in an early stage of development, including respiratory testing and sepsis (blood infection) panels. It markets a platform of molecular testing in small to medium sized hospitals.

Exactech Company Profile

Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.

Receive News & Ratings for Great Basin Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Great Basin Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.